Skip to content

Psychogenic and Neurogenic Components in Patients With Psychogenic or Neuropathic Pruritus

Psychogenic and Neurogenic Components in Patients With Psychogenic or Neuropathic Pruritus : PRURINEURO, a Pilot Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05024851
Acronym
PRURINEURO
Enrollment
40
Registered
2021-08-27
Start date
2021-08-25
Completion date
2022-07-08
Last updated
2024-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Itch, Neuropathic Pain, Pruritus, Psychogenic Skin Disease

Keywords

Psychogenic Pruritus, Neuropathic Pruritus, Psychogenic Component, Neurogenic Component

Brief summary

Scientific research on pruritus is in intensive development, with significant advances in understanding its pathophysiology. The causes of pruritus are very huge; they can be classified into different categories; we can find dermatological causes, systemic causes, neuropathic or neurological causes, psychogenic or even idiopathic causes. The diagnosis of psychogenic pruritus is often over stated, when no cause is found; therefore, it is important to see what is really relieving from psychic so as not to over-diagnose and adopt a therapy more in line with the real problem of the patient. In daily practice, it seems to have a tendency to separate psychogenic and neurogenic etiologies in the diagnosis of neuropathic or psychogenic pruritus. In the case of patients with psychogenic pruritus and neuropathic pruritus, no study has attempted to study the respective part of psychogenic and neurogenic components. Consequently, it would therefore be interesting to assess the areas of superposition and distinction of neuropathic and psychogenic pruritus. The aim of this pilot study is to assess the psychogenic and neurogenic components of psychogenic pruritus and neuropathic pruritus in order to improve understanding of the mechanism and therefore their management. The main objective of this study is to highlight the differences and the potential common characteristics between psychogenic and neuropathic pruritus in order to improve the differential diagnosis between these two pathologies. The secondary objective of this study is to describe the psychogenic and neurogenic characteristics of psychogenic and neuropathic pruritus.

Detailed description

PruriNeuro : Non-interventional single-center prospective study organized and practiced on humans for the development of medical knowledge, in which the data are obtained by validated questionnaires. The duration of participation is estimated at 1 hour. Questionnaires used : * Critères diagnostiques du prurit psychogène (Diagnosis criteria of functional itch disorder or psychogenic pruritus, from the French psychodermatology group) * NP5 questionnaire * Questionnaire de Brest * HADS * TAS-20 * DN4i

Interventions

OTHERQuestionnaires

Evaluation of the Psychogenic and Neurogenic Components using questionnaires

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major (\> 18 years old) * Diagnosis of psychogenic pruritus or neuropathic pruritus made in consultation, in day hospital or in hospital, within the dermatology department at the CHRU de Brest * Able to understand and agree to sign the information and non-opposition notice * No opposition of the patient

Exclusion criteria

* Patient under legal protection (guardianship, curatorship) * Minor (\<18 years old) * Acute or chronic condition which could limit the patient's ability to the study's participation * Inability to understand and sign the information and non-opposition notice * Refusal to give no opposition

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire de Brestat the enrollmentQualitative assessment of pruritus, specifying the chronology, location, intensity, characteristics and effect on daily activities of the itching induced by pruritus
HADS (Hospital Anxiety and Depression Scale)at the enrollmentTotal score for Depression or Anxiety 0-7 = Normal 8-10 = Borderline abnormal (borderline case) 11-21 = Abnormal (case)
NP5at the enrollmentA score of two criteria out of five is optimal to discriminate Neuropathic pruritus (NP) from Non-NP
TAS-20at the enrollmentThe TAS-20 is a self-report scale that is comprised of 20 items. Items are rated using a 5-point Likert scale whereby 1 = strongly disagree and 5 = strongly agree. There are 5 items that are negatively keyed (items 4, 5, 10, 18 and 19). The total alexithymia score is the sum of responses to all 20 items, while the score for each subscale factor is the sum of the responses to that subscale. The TAS-20 uses cutoff scoring: equal to or less than 51 = non-alexithymia, equal to or greater than 61 = alexithymia. Scores of 52 to 60 = possible alexithymia.
DN4iat the enrollmentscore equal to or greater than 3 : in favor of neuropathic pruritus
Diagnosis criteria of functional itch disorder or psychogenic pruritus, from the French psychodermatology groupat the enrollmentthree compulsory criteria; Three additional criteria from seven items should also be present

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026